Dupixent 200 MG/1.14 ML syring 1.14ML
Ended Awarded Last action
- Contract number
- SPE2DR26FGN2D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,556
Award facts
- Contract value 100% obligated
- $35,555.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $35.6K delivery order to Amerisourcebergen Drug Corp (via parent company Cencora, Inc.) on January 23, 2026, for the supply of Dupixent 200 mg/1.14 mL syringes with a completion date of January 26, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Conshohocken, Pennsylvania facility. Dupixent (dupilumab) is a biologic medication used to treat conditions including atopic dermatitis, asthma, and eosinophilic diseases, representing a specialty pharmaceutical product commonly procured through federal medical supply channels.
This delivery order falls under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.9M through December 2031, which serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs. The IDC enables efficient procurement of a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency operations, military treatment facilities, and other federal healthcare systems. Amerisourcebergen Drug Corp's role as a major pharmaceutical distributor positions it as a critical vendor in the federal medical supply chain, with extensive experience fulfilling competitively awarded delivery orders for brand-name and specialty medications essential to military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FGN2D?
SPE2DR26FGN2D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FGN2D worth?
The government has obligated $35,556 on SPE2DR26FGN2D.
Is contract SPE2DR26FGN2D an order under another contract?
Yes. SPE2DR26FGN2D is a delivery order under SPE2DR25D1002, an indefinite delivery contract.
Was contract SPE2DR26FGN2D competed?
The extent of competition for SPE2DR26FGN2D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award